Venu Bathini to Humans
This is a "connection" page, showing publications Venu Bathini has written about Humans.
Connection Strength
0.173
-
Javvaji C, Bledsoe JR, Hutchinson L, Cosar EF, McIntosh LJ, Bathini VG. Metastatic Signet Ring Cell Carcinoma of the Ampulla of Vater with an Unusually Prolonged Survival. J Gastrointest Cancer. 2020 Mar; 51(1):354-358.
Score: 0.026
-
Wang X, Mathew C, Korapati S, Bathini VG. Successful Long-term Anticoagulation with Enoxaparin in a Patient with a Mechanical Heart Valve. Pharmacotherapy. 2020 02; 40(2):174-177.
Score: 0.026
-
Al-Mansour Z, Pang L, Bathini V. Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? Drugs Aging. 2019 01; 36(1):1-11.
Score: 0.024
-
Saini NY, Bathini V. Large granular lymphocytic leukemia-associated peripheral neuropathy. Ann Hematol. 2018 Aug; 97(8):1501-1504.
Score: 0.023
-
Tipirneni E, Buttar A, Brettler D, Miron P, Bathini V. Chronic myeloproliferative disorder with ETV6-PDGFR? fusion gene. Ann Hematol. 2012 Apr; 91(4):637-8.
Score: 0.014
-
Buttar A, Mittal K, Khan A, Bathini V. Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma. Clin Breast Cancer. 2011 Oct; 11(5):342-5.
Score: 0.014
-
McIntosh LJ, Rosen MP, Mittal K, Whalen GF, Bathini VG, Ali T, Edmiston KL, Walsh WV, Gerber JM. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination. Cancer Treat Rev. 2021 Jul; 98:102220.
Score: 0.007
-
Zhu X, Jamshed S, Zou J, Azar A, Meng X, Bathini V, Dresser K, Strock C, Yalamarti B, Yang M, Tomaszewicz K, Tjionas G, Mochel MC, Hutchinson L, Bledsoe JR. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status. Mod Pathol. 2021 05; 34(5):1017-1030.
Score: 0.007
-
Philip PA, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo JL, Kim EJ, Dowden S, Zakari A, Borg C, Terrebonne E, Rivera F, Sastre J, Bathini V, L?pez-Trabada D, Asselah J, Saif MW, Shiansong Li J, Ong TJ, Nydam T, Hammel P. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Lancet Gastroenterol Hepatol. 2020 03; 5(3):285-294.
Score: 0.007
-
Zhu X, Salhab M, Tomaszewicz K, Meng X, Mathew C, Bathini V, Switzer B, Walter O, Cosar EF, Wang X, Lambert LA, Hutchinson LM. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms. Hum Pathol. 2019 03; 85:260-269.
Score: 0.006
-
Kodali S, Bathini V, Rava P, Tipirneni E. Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil. J Gastrointest Cancer. 2017 Mar; 48(1):66-69.
Score: 0.005
-
Li T, Piperdi B, Walsh WV, Kim M, Beckett LA, Gucalp R, Haigentz M, Bathini VG, Wen H, Zhou K, Pasquinelli PB, Gajavelli S, Sreedhara M, Xie X, Lara PN, Gandara DR, Perez-Soler R. Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer. Clin Lung Cancer. 2017 01; 18(1):60-67.
Score: 0.005
-
Piperdi B, Walsh WV, Bradley K, Zhou Z, Bathini V, Hanrahan-Boshes M, Hutchinson L, Perez-Soler R. Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer. J Thorac Oncol. 2012 Jun; 7(6):1032-40.
Score: 0.004
-
Tokh M, Bathini V, Saif MW. First-line treatment of metastatic pancreatic cancer. JOP. 2012 Mar 10; 13(2):159-62.
Score: 0.004